本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

38.57
-1.9400-4.79%
盘后38.00-0.5700-1.48%18:21 EDT
成交量:54.58万
成交额:2,096.50万
市值:42.65亿
市盈率:-15.55
高:38.89
开:38.14
低:37.18
收:40.51
数据加载中...
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/23

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]